Log in

NYSE:CTVACorteva Stock Price, Forecast & News

$24.54
-0.01 (-0.04 %)
(As of 05/22/2020 04:00 PM ET)
Add
Compare
Today's Range
$24.25
Now: $24.54
$24.67
50-Day Range
$22.24
MA: $25.09
$27.93
52-Week Range
$20.38
Now: $24.54
$32.78
Volume3.83 million shs
Average Volume4.14 million shs
Market Capitalization$18.36 billion
P/E RatioN/A
Dividend Yield2.12%
BetaN/A
Corteva, Inc. provides agriculture products worldwide. The company develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. It also supplies products to the agricultural input industry that protect against weeds, insects and other pests, and diseases, as well as to enhance crop health. The company is based in Wilmington, Delaware. Corteva, Inc. operates independently of DowDuPont Inc. as of June 1, 2019.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 2.2Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.20 out of 5 stars


Industry, Sector and Symbol

Industry Agricultural production - crops
Sub-IndustryN/A
SectorConsumer Staples
CUSIPN/A
CIKN/A
Phone302-485-3000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.85 billion
Cash Flow$5.41 per share
Book Value$32.17 per share

Profitability

Net Income$-959,000,000.00

Miscellaneous

EmployeesN/A
Market Cap$18.36 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableNot Optionable

Receive CTVA News and Ratings via Email

Sign-up to receive the latest news and ratings for CTVA and its competitors with MarketBeat's FREE daily newsletter.

Corteva (NYSE:CTVA) Frequently Asked Questions

How has Corteva's stock been impacted by COVID-19 (Coronavirus)?

Corteva's stock was trading at $25.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CTVA stock has decreased by 1.8% and is now trading at $24.54. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Corteva?

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corteva in the last year. There are currently 1 sell rating, 13 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Corteva.

When is Corteva's next earnings date?

Corteva is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Corteva.

How were Corteva's earnings last quarter?

Corteva (NYSE:CTVA) posted its quarterly earnings results on Wednesday, May, 6th. The company reported $0.59 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.20. The business had revenue of $3.96 billion for the quarter, compared to analyst estimates of $3.56 billion. Corteva had a negative net margin of 5.91% and a positive return on equity of 5.09%. Corteva's quarterly revenue was up 16.5% compared to the same quarter last year. View Corteva's earnings history.

How often does Corteva pay dividends? What is the dividend yield for Corteva?

Corteva declared a quarterly dividend on Tuesday, April 28th. Shareholders of record on Friday, May 15th will be given a dividend of $0.13 per share on Monday, June 15th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 2.12%. The ex-dividend date of this dividend is Thursday, May 14th. View Corteva's dividend history.

What price target have analysts set for CTVA?

27 brokerages have issued twelve-month price objectives for Corteva's shares. Their forecasts range from $24.00 to $39.00. On average, they expect Corteva's share price to reach $30.47 in the next year. This suggests a possible upside of 24.2% from the stock's current price. View analysts' price targets for Corteva.

Has Corteva been receiving favorable news coverage?

Media coverage about CTVA stock has been trending somewhat negative this week, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Corteva earned a news sentiment score of -1.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next few days. View the latest news aboutCorteva.

Are investors shorting Corteva?

Corteva saw a increase in short interest in May. As of May 15th, there was short interest totaling 10,680,000 shares, an increase of 19.7% from the April 30th total of 8,920,000 shares. Based on an average daily trading volume, of 5,080,000 shares, the short-interest ratio is presently 2.1 days. Currently, 1.4% of the company's shares are short sold. View Corteva's Current Options Chain.

Who are some of Corteva's key competitors?

What other stocks do shareholders of Corteva own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Corteva investors own include Dow Chemical (DOW), Cisco Systems (CSCO), AT&T (T), CVS Health (CVS), Verizon Communications (VZ), E I Du Pont De Nemours And Co (DD), Home Depot (HD), Johnson & Johnson (JNJ), NVIDIA (NVDA) and Walt Disney (DIS).

What is Corteva's stock symbol?

Corteva trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTVA."

Who are Corteva's major shareholders?

Corteva's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.78%), State Street Corp (5.70%), Aristotle Capital Management LLC (3.33%), Invesco Ltd. (2.99%), Geode Capital Management LLC (1.63%) and Capital World Investors (1.54%). Company insiders that own Corteva stock include Cornel B Fuerer, Gregory R Friedman, Gregory R Page, James C Jr Collins, Klaus A Engel and Timothy P Glenn. View institutional ownership trends for Corteva.

Which institutional investors are selling Corteva stock?

CTVA stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, JPMorgan Chase & Co., Mackenzie Financial Corp, Nuveen Asset Management LLC, State Street Corp, Clearbridge Investments LLC, TCW Group Inc., and Confluence Investment Management LLC. View insider buying and selling activity for Corteva.

Which institutional investors are buying Corteva stock?

CTVA stock was bought by a variety of institutional investors in the last quarter, including Aristotle Capital Management LLC, Van ECK Associates Corp, Janus Henderson Group PLC, Principal Financial Group Inc., Factory Mutual Insurance Co., Swiss National Bank, Invesco Ltd., and Natixis Advisors L.P.. Company insiders that have bought Corteva stock in the last two years include Cornel B Fuerer, Gregory R Friedman, Gregory R Page, James C Jr Collins, Klaus A Engel, and Timothy P Glenn. View insider buying and selling activity for Corteva.

How do I buy shares of Corteva?

Shares of CTVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Corteva's stock price today?

One share of CTVA stock can currently be purchased for approximately $24.54.

How big of a company is Corteva?

Corteva has a market capitalization of $18.36 billion and generates $13.85 billion in revenue each year. The company earns $-959,000,000.00 in net income (profit) each year or $1.43 on an earnings per share basis.

What is Corteva's official website?

The official website for Corteva is www.corteva.com.

How can I contact Corteva?

Corteva's mailing address is 974 CENTRE ROAD, WILMINGTON DE, 19805. The company can be reached via phone at 302-485-3000.

This page was last updated on 5/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.